Cargando…

Bi-specific splice-switching PMO oligonucleotides conjugated via a single peptide active in a mouse model of Duchenne muscular dystrophy

The potential for therapeutic application of splice-switching oligonucleotides (SSOs) to modulate pre-mRNA splicing is increasingly evident in a number of diseases. However, the primary drawback of this approach is poor cell and in vivo oligonucleotide uptake efficacy. Biological activities can be s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shabanpoor, Fazel, McClorey, Graham, Saleh, Amer F., Järver, Peter, Wood, Matthew J.A., Gait, Michael J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2015
Materias:	Chemical Biology and Nucleic Acid Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288157/ https://www.ncbi.nlm.nih.gov/pubmed/25468897 http://dx.doi.org/10.1093/nar/gku1256

Ejemplares similares

Comparison of the efficacy of MOE and PMO modifications of systemic antisense oligonucleotides in a severe SMA mouse model
por: Sheng, Lei, et al.
Publicado: (2020)

Control of backbone chemistry and chirality boost oligonucleotide splice switching activity
por: Kandasamy, Pachamuthu, et al.
Publicado: (2022)

Palmitic acid conjugation enhances potency of tricyclo-DNA splice switching oligonucleotides
por: Relizani, Karima, et al.
Publicado: (2021)

Dual Myostatin and Dystrophin Exon Skipping by Morpholino Nucleic Acid Oligomers Conjugated to a Cell-penetrating Peptide Is a Promising Therapeutic Strategy for the Treatment of Duchenne Muscular Dystrophy
por: Malerba, Alberto, et al.
Publicado: (2012)

Peptide Nanoparticle Delivery of Charge-Neutral Splice-Switching Morpholino Oligonucleotides
por: Järver, Peter, et al.
Publicado: (2015)

Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
por: Coenen-Stass, Anna M. L., et al.
Publicado: (2015)

Implications for Cardiac Function Following Rescue of the Dystrophic Diaphragm in a Mouse Model of Duchenne Muscular Dystrophy
por: Betts, Corinne A., et al.
Publicado: (2015)

Delivery of oligonucleotides to bone marrow to modulate ferrochelatase splicing in a mouse model of erythropoietic protoporphyria
por: Halloy, François, et al.
Publicado: (2020)

Enhanced delivery of peptide-morpholino oligonucleotides with a small molecule to correct splicing defects in the lung
por: Dang, Yan, et al.
Publicado: (2021)

7′,5′-alpha-bicyclo-DNA: new chemistry for oligonucleotide exon splicing modulation therapy
por: Evéquoz, Damien, et al.
Publicado: (2021)

Development of a general methodology for labelling peptide–morpholino oligonucleotide conjugates using alkyne–azide click chemistry
por: Shabanpoor, Fazel, et al.
Publicado: (2013)

Corrigendum: Identification of novel, therapy-responsive protein biomarkers in a mouse model of Duchenne muscular dystrophy by aptamer-based serum proteomics
por: Coenen-Stass, Anna M. L., et al.
Publicado: (2016)

Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
por: Prakash, Thazha P, et al.
Publicado: (2019)

Targeted tissue delivery of RNA therapeutics using antibody–oligonucleotide conjugates (AOCs)
por: Malecova, Barbora, et al.
Publicado: (2023)

Peptide-conjugated phosphodiamidate oligomer-mediated exon skipping has benefits for cardiac function in mdx and Cmah-/-mdx mouse models of Duchenne muscular dystrophy
por: Blain, Alison M., et al.
Publicado: (2018)

Strict conformational demands of RNA cleavage in bulge-loops created by peptidyl-oligonucleotide conjugates
por: Staroseletz, Yaroslav, et al.
Publicado: (2020)

Conjugation of hydrophobic moieties enhances potency of antisense oligonucleotides in the muscle of rodents and non-human primates
por: Østergaard, Michael E, et al.
Publicado: (2019)

Challenges to oligonucleotides-based therapeutics for Duchenne muscular dystrophy
por: Goyenvalle, Aurélie, et al.
Publicado: (2011)

Elasticity of the transition state for oligonucleotide hybridization
por: Whitley, Kevin D., et al.
Publicado: (2017)

Modular protein-oligonucleotide signal exchange
por: Agrawal, Deepak K, et al.
Publicado: (2020)

Towards next generation antisense oligonucleotides: mesylphosphoramidate modification improves therapeutic index and duration of effect of gapmer antisense oligonucleotides
por: Anderson, Brooke A, et al.
Publicado: (2021)

Chemical ligation of oligonucleotides using an electrophilic phosphorothioester
por: Maruyama, Hideto, et al.
Publicado: (2017)

Weak tension accelerates hybridization and dehybridization of short oligonucleotides
por: Hart, Derek J, et al.
Publicado: (2023)

Splice-Switching Therapy for Spinal Muscular Atrophy
por: Meijboom, Katharina E., et al.
Publicado: (2017)

PMO-based let-7c site blocking oligonucleotide (SBO) mediated utrophin upregulation in mdx mice, a therapeutic approach for Duchenne muscular dystrophy (DMD)
por: Sengupta, Kasturi, et al.
Publicado: (2020)

Prevention of exercised induced cardiomyopathy following Pip-PMO treatment in dystrophic mdx mice
por: Betts, Corinne A., et al.
Publicado: (2015)

Influence of 5-N-carboxamide modifications on the thermodynamic stability of oligonucleotides
por: Wolk, Steven K., et al.
Publicado: (2015)

Pseudorotaxane formation via the slippage process with chemically cyclized oligonucleotides
por: Onizuka, Kazumitsu, et al.
Publicado: (2017)

Programmable manipulation of oligonucleotide–albumin interaction for elongated circulation time
por: Yang, Cai, et al.
Publicado: (2022)

Hybridization kinetics of out-of-equilibrium mixtures of short RNA oligonucleotides
por: Todisco, Marco, et al.
Publicado: (2022)

Identification of a Peptide for Systemic Brain Delivery of a Morpholino Oligonucleotide in Mouse Models of Spinal Muscular Atrophy
por: Shabanpoor, Fazel, et al.
Publicado: (2017)

Structural optimization of pseudorotaxane-forming oligonucleotides for efficient and stable complex formation
por: Onizuka, Kazumitsu, et al.
Publicado: (2018)

Identification of nucleobase chemical modifications that reduce the hepatotoxicity of gapmer antisense oligonucleotides
por: Yoshida, Tokuyuki, et al.
Publicado: (2022)

Displacement and dissociation of oligonucleotides during DNA hairpin closure under strain
por: Ding, Fangyuan, et al.
Publicado: (2022)

Controlled sulfur-based engineering confers mouldability to phosphorothioate antisense oligonucleotides
por: Genna, Vito, et al.
Publicado: (2023)

High-throughput screening identifies small molecules that enhance the pharmacological effects of oligonucleotides
por: Yang, B., et al.
Publicado: (2015)

Rational design of antisense oligonucleotides modulating the activity of TLR7/8 agonists
por: Alharbi, Arwaf S, et al.
Publicado: (2020)

Enzymatic Synthesis of Chemical Nuclease Triplex-Forming Oligonucleotides with Gene-Silencing Applications
por: McGorman, Bríonna, et al.
Publicado: (2022)

Short LNA-modified oligonucleotide probes as efficient disruptors of DNA G-quadruplexes
por: Chowdhury, Souroprobho, et al.
Publicado: (2022)

Enhancing antisense efficacy with multimers and multi-targeting oligonucleotides (MTOs) using cleavable linkers
por: Subramanian, Romesh R., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_vdbbb1kl6q6df5bik3imkrl7e5